Back to results
US 2026/0103438 A1Published application
Probes and methods to identify ligandable fatty acylation sites for therapeutic target identification
OwnerXu Wu, Lu Huinventors
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to compounds of Formula I and methods comprising the use of these compounds to identify ligandable fatty acylation sites.
Claims21
A compound according to Formula I:
- or a pharmaceutically acceptable salt thereof, wherein
- n is 9, 10, 11, 12, 13, or 14;
- R1 is H or halogen;
- m is 0 or 1;
- and
- R2 is H, —C(═O)—RA, or —S(O)2—RA;
- wherein RA is C2-6 alkenyl or C1-6 haloalkyl.
4 more elements
Dependencies are inferred from the claim text.